Your Trusted Partner in Analysis and Biosensors
Cutting-edge Innovations for Your Research
Our Innovations Technology
Patented Bridge-It® Assay Platform
Mediomics’ Bridge-It® assay was based on a simple idea of splitting the DNA binding site for a protein into two DNA half-sites. The presence of the DNA-binding protein or one of its ligands can be detected by FRET (fluorescence resonance energy transfer).
Patented FRET-PINCER® Assay Platform
Patented TRF-PINCER® Assay Platform
Our platform technologies have already been adapted for the detection of a range of important macromolecules, including cAMP, tryptophan, S-adenosyl methionine, PDE, biotin, insulin, C-peptide, albumin, C-reactive protein (hCRP), IgG, IgM, E. coli, and others.
Featured Product
References
If you would like to add a publication that uses one of our products, please contact us and we would be happy to include it.
Technology History
Mediomics’ Bridge-it® assay (Fig. 1A) was based on a simple idea of splitting the DNA binding site for a protein into two DNA “half-sites”.
References
If you would like to add a publication that uses one of our products, please contact us and we would be happy to include it.
Technology History
Mediomics’ Bridge-it® assay (Fig. 1A) was based on a simple idea of splitting the DNA binding site for a protein into two DNA “half-sites”.
